Evolus (EOLS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

EOLS is expected to report earnings to fall 33.44% to -11 cents per share on November 05

Q3'24

Est.

$-0.12

Q2'24

Missed

by $0.13

Q1'24

Missed

by $0.07

Q4'23

Missed

by $0.09

Q3'23

Missed

by $0.08

The last earnings report on July 31 showed earnings per share of -18 cents, missing the estimate of -5 cents. With 873.03K shares outstanding, the current market capitalization sits at 846.82M.

View a ticker or compare two or three

Compare

EOLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EOLS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for EOLS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of neurotoxins

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

520 Newport Center Drive

Phone

+1 949 284-4555

Employees

273

Web

https://www.evolus.com